Press Releases

Ginkgo Bioworks Acquires Leading Synthetic DNA Provider Gen9

  • January 20, 2017

Acquisition brings unprecedented scale and speed to organism design

READ MORE

Auburn University, Autodesk, and Gen9 Collaborate to Create Longest Synthetic Virus for Cancer Research

  • November 2, 2016

Synthetic DNA virus used in canine research will inform the development of human cancer therapies, could revolutionize approach to personalized medicine for cancer treatment

READ MORE

Gen9 Announces University of East Anglia and Start-up Company Biosyntia are Winners of Fourth Annual G-Prize

1 million base pairs of DNA awarded to support leading-edge projects in plant cell signaling and vitamin cell factory development

READ MORE

Gen9 to Supply Ginkgo Bioworks with 300 Million Base Pairs of Synthetic DNA for Pathway Engineering

In unprecedented deal, Ginkgo partners with Gen9 for massive quantities of long-length DNA critical to metabolic pathway engineering across multiple industries

READ MORE

Gen9 and Amyris Announce Supply Agreement for Synthetic DNA

  • June 2, 2016

Amyris joins Gen9’s MAP program to purchase mass quantities of synthetic DNA for development of high performance renewable products

READ MORE

Gen9 and Arzeda Announce Supply Agreement for Synthetic DNA

Arzeda joins Gen9’s MAP program to purchase mass quantities of high-quality synthetic DNA for development of sustainable industrial chemicals

READ MORE

Gen9 Announces Next Generation of the BioFab® DNA Synthesis Platform

  • March 22, 2016

Technology enables game-changing economics of 3 cents per base pair for industrial use of synthetic DNA

READ MORE

Gen9 and SynbiCITE Announce Partnership to Accelerate Technology Commercialization through Synthetic Biology

  • February 17, 2016

Gen9 synthetic DNA to fuel innovations by SynbiCITE community

READ MORE

Gen9 Develops Novel Multiplex Synthesis Platform for DNA Assembly

  • February 9, 2016

Proprietary technology enables manufacture of billions of base pairs of DNA at a fraction of today’s costs

READ MORE

Gen9 Chief Legal Officer Jennifer Camacho Appointed to Prestigious USPTO Advisory Committee

  • January 11, 2016

Gen9 Chief Legal Officer Jennifer Camacho has been appointed by the U.S. Secretary of Commerce to the Patent Public Advisory Committee (PPAC) of the U.S. Patent and Trademark Office (USPTO).

READ MORE